CRH Medical posted revenues of $29.1 million for the first quarter of 2019.
Exact Sciences posted first-quarter 2019 revenues of $162 million, a 79 percent year-over-year increase.
For the first quarter, Pacira BioSciences reported record sales of Exparel, a non-opioid pain management drug that became eligible for separate Medicare reimbursement in ASCs as of Jan. 1.
Specialty biopharmaceutical company EyePoint Pharmaceuticals reported $2 million in revenue for the first quarter of 2019, up from $928,000 year over year.
More articles on gastroenterology:
2 Texas clinicians unintentionally compromise patient information — 6 insights
AGA joins ‘Let My Doctor Decide’ to fight step therapy
Motus readies for commercial launch of Pure-Vu, posts $5.2M net loss for Q1 — 3 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
